Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors

Neuroendocrine serum markers released from prostate cancers have been proposed for monitoring disease and predicting survival. However, neuroendocrine differentiation (NED) in various tissue compartments of metastatic prostate cancer is poorly described and its correlation with specific tumor featur...

Descripción completa

Detalles Bibliográficos
Autores principales: Genitsch, Vera, Zlobec, Inti, Seiler, Roland, Thalmann, George N., Fleischmann, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578030/
https://www.ncbi.nlm.nih.gov/pubmed/28788048
http://dx.doi.org/10.3390/ijms18081640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578030/
https://www.ncbi.nlm.nih.gov/pubmed/28788048
http://dx.doi.org/10.3390/ijms18081640

Ejemplares similares